A new lab-made drug slowed glioblastoma tumors in mice
Original title: Design, synthesis and anti-glioblastoma multiforme activity of N-methoxy-2-(pyrimidin-4-ylamino)benzamide derivatives as focal adhesion kinase inhibitors.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab dishes and in mice, not in people.
The short version
Scientists built a new chemical that blocked a protein glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary needs, and it shrank tumor growth in mice.
What was studied. Researchers designed and made eighteen new chemical compounds aimed at a protein called FAK, which helps glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary grow and spread. They tested the compounds on glioblastoma cells in the lab, and tested the best one in mice with glioblastoma tumors.
What they found. One compound, called 7h, worked best. In lab dishes it blocked FAK and slowed glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cell growth better than an older drug called TAE-226. In mice, a daily dose of 10 mg/kg slowed tumor growth by 54.1%, compared with 50.1% for TAE-226. A higher daily dose of 20 mg/kg slowed tumor growth by 83.44%. Lab tests also suggested the compound could pass into the brain, but that still needs to be tested in animals.
What this means, and what it doesn't
What it could mean: This is an early sign that blocking FAK with a better designed drug might one day help fight glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. Right now it means nothing for your treatment. It is a starting point for more research.
What it doesn't mean: This does not mean a new treatment is coming soon. The work was done in cells in a dish and in mice. No person has been given this compound. Older drugs aimed at the same protein were tested in people and none were approved. Most compounds at this stage never become a medicine. This is not a cure, and it is not a promise of one.
Source: PubMed, July 23, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.